These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 3734795)

  • 1. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain.
    Ross SB
    J Neurochem; 1987 Feb; 48(2):609-14. PubMed ID: 3098921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
    Fagervall I; Ross SB
    J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
    Fagervall I; Kelder D; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
    Ask AL; Fagervall I; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.
    Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
    Neuropharmacology; 1986 Jan; 25(1):33-40. PubMed ID: 3005903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB
    Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
    Waldmeier PC; Delini-Stula A; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):9-14. PubMed ID: 934359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogenesis of enzyme systems deaminating different monoamines.
    Blatchford D; Holzbauer M
    Br J Pharmacol; 1976 Jun; 57(2):279-93. PubMed ID: 938797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ; King J; Kotzuk J; Schoepp DD; Frost J; Schochet S
    J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
    Demarest KT; Smith DJ; Azzaro AJ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):461-8. PubMed ID: 7441510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intra- and extrasynaptosomal monoamine oxidase-A and -B activities in the striatum and frontal cortex of two mice strains with different sensitivities to the neurotoxic actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Stenström A; Sundström E; Fowler CJ
    Pharmacol Toxicol; 1989 Mar; 64(3):276-81. PubMed ID: 2786196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
    Fagervall I; Ross SB
    Neuropharmacology; 1986 Aug; 25(8):911-3. PubMed ID: 3490629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species.
    Stenström A; Hardy J; Oreland L
    Biochem Pharmacol; 1987 Sep; 36(18):2931-5. PubMed ID: 3632718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system.
    Morón JA; Perez V; Fernández-Alvarez E; Marco JL; Unzeta M
    J Neural Transm Suppl; 1998; 52():343-9. PubMed ID: 9564637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
    Azzaro AJ; Amedro JB; Brown LM; Smith DJ; Williams GM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):9-13. PubMed ID: 2467212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.